Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Syndrome of Inappropriate ADH-secretion”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Not applicableUnknownNCT06171100
What this trial is testing

Low-dose Tolvaptan for Inpatient Hyponatraemia.

Who this might be right for
HyponatremiaSIADH
King's College Hospital NHS Trust 180
Not applicableUnknownNCT01509170
What this trial is testing

The Clinical and Laboratory Characteristics of Recurrent Drug- Related Hyponatremia

Who this might be right for
HyponatremiaSIADH
Hadassah Medical Organization 500
Large-scale testing (Phase 3)Ended earlyNCT00728091
What this trial is testing

A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia

Who this might be right for
HyponatremiaInappropriate ADH Syndrome
Sanofi 2
Not applicableStudy completedNCT01056848
What this trial is testing

International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430

Who this might be right for
Hyponatremia With Normal Extracellular Fluid VolumeHyponatremia With Excess Extracellular Fluid Volume
CardioKine Inc. 135
Post-approval studies (Phase 4)WithdrawnNCT00298753
What this trial is testing

Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine

Who this might be right for
Syndrome of Inappropriate ADH-secretion
Regional Hospital Holstebro
Large-scale testing (Phase 3)Study completedNCT02874807
What this trial is testing

Effects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND Study

Who this might be right for
SIADH
University Hospital, Basel, Switzerland 88
Not applicableStudy completedNCT06277336
What this trial is testing

Effects of Intravenous [Pyr1]Apelin-13 on Healthy Volunteers With Artificially Induced SIAD

Who this might be right for
SIAD - Syndrome of Inappropriate AntidiuresisHyponatremia
University Hospital, Basel, Switzerland 15
Large-scale testing (Phase 3)Ended earlyNCT01227512
What this trial is testing

Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia

Who this might be right for
HyponatremiaDilutional HyponatremiaInappropriate ADH Syndrome
Otsuka Pharmaceutical Development & Commercialization, Inc. 124
Large-scale testing (Phase 3)Study completedNCT00264914
What this trial is testing

Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion

Who this might be right for
Inappropriate ADH SyndromeHyponatremia
Sanofi 57
Not applicableWithdrawnNCT01425125
What this trial is testing

Fractional Urate Excretion in Nonedematous Hyponatremia

Who this might be right for
Cerebral HyponatremiaSIADHCerebral Salt-wasting Syndrome+1 more
NYU Langone Health
Not applicableStudy completedNCT01341665
What this trial is testing

Subclassification of the Syndrome of Inappropriate ADH Secretion

Who this might be right for
Hyponatremia
University of Wuerzburg 50
Large-scale testing (Phase 3)Study completedNCT00072683
What this trial is testing

"SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia

Who this might be right for
HyponatremiasWater IntoxicationInappropriate ADH Syndrome+1 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 240
Not applicableEnded earlyNCT02545114
What this trial is testing

Tolvaptan for Patients With Acute Neurological Injuries

Who this might be right for
HyponatremiaSIADH
Polderman, Kees, H., MD, PhD 25
Testing effectiveness (Phase 2)Study completedNCT02009878
What this trial is testing

A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)

Who this might be right for
Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Otsuka Pharmaceutical Development & Commercialization, Inc. 30
Large-scale testing (Phase 3)Study completedNCT00201994
What this trial is testing

"SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia

Who this might be right for
HyponatremiaWater IntoxicationInappropriate ADH Syndrome+1 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 243
Not applicableStudy completedNCT02545101
What this trial is testing

An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH

Who this might be right for
HyponatremiaSyndrome of Inappropriate ADH (SIADH) Secretion
Otsuka Pharmaceutical Europe Ltd 100
Large-scale testing (Phase 3)Study completedNCT03048747
What this trial is testing

Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH

Who this might be right for
Syndrome of Inappropriate Antidiuretic Hormone Secretion
Otsuka Pharmaceutical Co., Ltd. 16
Not applicableLooking for participantsNCT07528365
What this trial is testing

Urea for Treatment of Hyponatremia in Patients With SIAD Unresponsive to Fluid Restriction

Who this might be right for
SIAD - Syndrome of Inappropriate Antidiuresis
University of Turin, Italy 20
Not applicableStudy completedNCT02573077
What this trial is testing

An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy

Who this might be right for
HyponatremiaSyndrome of Inappropriate ADH (SIADH) SecretionCancer
Otsuka Pharmaceutical Europe Ltd 69
Not applicableStudy completedNCT02548845
What this trial is testing

An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in Spain

Who this might be right for
HyponatremiaSyndrome of Inappropriate ADH (SIADH) Secretion
Otsuka Pharmaceutical Europe Ltd 70
Load More Results